We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
Prosecution: Argument for BRAF/MEK-Targeted Adjuvant Treatment of Stage III Melanoma
Omid Hamid, MD
Sapna Patel, MD
Ryan Sullivan, MD
Jeffrey S. Weber, MD, PhD
Defense: Argument for Single Agent ICI Adjuvant Treatment of Stage III Melanoma
Jason J. Luke, MD, FACP
Directed Relief in CKD-aP: Linking Targeted Therapy to Clinical Outcomes
Thilo Krüger, MD, PhD
Steven Fishbane, MD
Lucio Manenti, MD, PhD
KALMing the Itch: Improving QoL in Patients with CKD-aP
Joel Topf, MD
Kieran McCafferty, MD
Preventing Disease Recurrence with Adjuvant Therapy in Stage IIB/IIC Melanoma
Tara C. Mitchell, MD
Separating Fact from Fiction: The Realities of CKD-aP
Carol Pollock, AO, MBBS, PhD, FRACP, FAHMS
Antoine Lanot, MD, PhD
Using a Biologic in a Patient with Atopic Dermatitis and HSV Keratitis
Peter A. Lio, MD
Mark Boguniewicz, MD
Eric Simpson, MD, MCR
Combining Biologics in a Young Patient with Atopic Dermatitis
Options for an Infant with Atopic Dermatitis
Advances in the Management of Moderate-to-Severe Atopic Dermatitis
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education